JNJ

Johnson & Johnson (JNJ), classified in the Health Care sector, has drawn disclosed trading activity from 38 distinct members of Congress across 136 total transactions spanning from October 2019 through June 2026, with purchases outnumbering sales 79 to 57 in net buying. The most-active disclosers by trade count are Ro Khanna, Lloyd Doggett, Josh Gottheimer, and Kevin Hern, and the record shows 10 bipartisan co-trading clusters involving this name. In parallel, 48 executive-branch officials have disclosed 84 separate transactions in the same security, with the closest congressional and executive purchases falling zero days apart in the public filing record — a sequence observed across independent disclosure systems. The breadth of participation across both chambers and branches reflects a widely held large-cap health care name with consistent multi-year activity.